Fox Run Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,556
Closed -$115K 757
2021
Q3
$115K Buy
+13,556
New +$115K 0.07% 419